{"doi":"10.1093/aje/kwae461","title":"Nonfatal suicidal self-directed violence among US veterans (2022): the Assessing Social and Community Environments with National Data (ASCEND) for Veteran Suicide Prevention Study","abstract":"From 2001 to 2021, the age- and sex-adjusted veteran suicide rate in the United States increased 76.3%. Surveillance of suicidal ideation (SI) and nonfatal suicidal self-directed violence (NF-SSDV) is a critical component of public health-oriented suicide prevention efforts. To facilitate national NF-SSDV surveillance, a biennial, population-based survey was initiated: Assessing Social and Community Environments with National Data (ASCEND) for Veteran Suicide Prevention. A total of 17 396 veterans participated in the first large-scale ASCEND survey (2022). This article reports on SI and NF-SSDV prevalence among veterans residing in the continental United States, Hawaii, and Puerto Rico. Lifetime SI was reported by 31.98% (95% CI, 30.97-32.99), post-military SI by 25.88% (95% CI, 24.91-26.85), and past-year SI by 12.69% (95% CI, 11.90-13.47). The most commonly considered SI method among those with past-year SI was gunshot. Additionally, 36.87% (95% CI, 34.84-38.90) of veterans with lifetime SI reported lifetime preparatory behaviors. Moreover, 9.13% (95% CI, 8.43-9.82) of veterans reported lifetime interrupted attempts. Lifetime suicide attempts (SAs) were reported by 6.99% (95% CI, 6.41-7.56) of veterans, with 4.88% (95% CI, 4.39-5.36) reporting post-military SA. The most common method in prior attempts was medication overdose. ASCEND provides a novel opportunity to elucidate the prevalence of SI and different types of NF-SSDV in the veteran population. Recurring administration will elucidate changes in SI and NF-SSDV prevalence in the veteran population over time.","journal":"American Journal of Epidemiology","year":2024,"id":455075,"datarank":0.31191623125197543,"base_score":2.0794415416798357,"endowment":2.0794415416798357,"self_citation_contribution":0.31191623125197543,"citation_network_contribution":0.0,"self_endowment_contribution":0.31191623125197543,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":7,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.521,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1278911,"name":"Sean M. Barnes","orcid":"0000-0002-6010-4421","position":1,"is_corresponding":false},{"id":675147,"name":"Ryan Holliday","orcid":"0000-0002-9896-1904","position":2,"is_corresponding":false},{"id":1278912,"name":"Julie A. Kittel","orcid":"0000-0002-7911-2990","position":3,"is_corresponding":false},{"id":938704,"name":"Alexandra L. Schneider","orcid":null,"position":4,"is_corresponding":false},{"id":256090,"name":"Lisa A. Brenner","orcid":"0000-0002-2629-214X","position":5,"is_corresponding":false},{"id":1278913,"name":"Jamie L. Tock","orcid":"0000-0003-1950-4420","position":6,"is_corresponding":false},{"id":675145,"name":"Lindsey L. Monteith","orcid":"0000-0002-8104-5280","position":7,"is_corresponding":false},{"id":936230,"name":"Claire A. Hoffmire","orcid":"0000-0002-8542-2581","position":0,"is_corresponding":true}],"reference_count":36,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:03:17.458329Z","pmid":"39694860","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}